BSTZ: Better Positioned To Capture Growth Of The AI Market

Trading at a 9.22% discount to NAV with an 8.8% yield, BlackRock Science and Technology Term Trust (BSTZ) is maintained as a buy. Concentrated exposure to semiconductors and private AI-driven companies positions the fund to benefit from sector growth through 2026, and eliminating options strategies allows BSTZ to fully capture upside in bull markets. The primary downside is reliance on net realized gains, which raises NAV erosion risk in market downturns.

Analysis

BSTZ’s concentrated exposure to semiconductors and private AI names creates pronounced convexity: if end-market AI capex continues to compound through 2025–26, expect 30–60% upside in select equipment and foundry names versus 10–20% in broad tech — the fund will amplify that asymmetry but also import higher idiosyncratic volatility. Second-order supply-chain effects matter: tight capacity in advanced nodes (substrates, EUV availability, test/pack) will transmit to upstream equipment orders and pricing power for ASML/LRCX/AMAT over 6–18 months, benefiting funds long this exposure while stressing legacy CPU/PC incumbents whose refresh cycles lag.

Removing options writing removes a structural income cushion; in rising markets this is pure upside capture, but in a >20% drawdown the fund lacks the option-premium buffer that peers have and will likely crystallize gains/losses to manage distributions, accelerating NAV erosion. The private AI portfolio introduces liquidity and mark risk — a funding shock or VC pullback in a 6–12 month window can force markdowns that are asymmetric relative to listed semis’ operational cash flows.

Catalysts to watch: quarterly capex guides from the top 5 semiconductor OEMs, wafer fab utilization prints, and VC funding pace for AI startups (data points over the next 3–9 months). Tail risks include a sudden slowdown in model training demand, a macro shock that compresses multiples across tech, or a policy intervention on advanced node exports; any of these could widen valuation dispersion and the fund’s discount, while an AMD/NVDA-led surge would compress it rapidly.

Key Decisions for Investors

• Buy BSTZ (3–5% portfolio weight) paired with a 50–75% notional short in QQQ (or XLK) to isolate concentrated semiconductor/AI upside (6–12 month horizon). Target total return 20–30% if semiconductors re-rate; cut to 1% weight if NVDA/TSMC guidance misses by >15% or if sector breadth narrows.
• Express upstream supply tightness with a 12–24 month pair: long ASML (ASML) + long Lam Research (LRCX) equal-weight, funded by shorting mature-software/legacy-exposure name (e.g., ORCL) — aim for asymmetric 2:1 upside/downside given secular capex cycle; use 15–20% trailing stop on each leg.
• If conviction in an AI-driven re-rating is high, buy LEAP call spreads on NVDA (buy 2026 Jan ITM, sell higher strike to finance) sizing for a 1–2% portfolio delta — expect 3x+ upside if NVDA sustains revenue beat cadence over next 12 months; cut if model-training demand growth <30% YoY for two consecutive quarters.
• Protect exposure: buy BSTZ 6–9 month put spreads (defined-cost) sized at 25–30% of long position or overlay 3–6 month put on NVDA/TWX if liquidity cheaper — cap downside while retaining upside capture, acceptable cost if you expect >20% volatility expansion in next 3 months.